 |
Phenol, 4-[2-(aminomethyl)-4-thiazolyl]-2,6-bis(1,1-dimethylethyl)monohydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Huntington disease |
| EU Market Approval | EU |
| EU Designation Date | 2015-04-24 00:00:00 |
| Sponsor | Ipsen Pharma |
Related Access Program
| |
Phenol, 4-[2-(aminomethyl)-4-thiazolyl]-2,6-bis(1,1-dimethylethyl)monohydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Huntington disease |
| EU Market Approval | EU |
| EU Designation Date | 2015-04-24 00:00:00 |
| Sponsor | Ipsen Pharma |